BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Discontinued
Traders Wobble On Merck KGaA (MKGAF.PK) After Stimuvax Stop 9/12/2014
Bay Area's Hyperion Therapeutics (HPTX) Tanks As Employee Misconduct Leads To Drug Trial Halt 9/10/2014
Second Failure Of The Month As Targacept, Inc. (TRGT) Halts Development Of Bladder Drug, Shares Plunge 7/30/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Terminates Development Of Top Prostate Cancer Prospect Orteronel 6/20/2014
Johnson & Johnson (JNJ) Halts Development Of Botox Rival, Axes Staffers 4/15/2014
Forest Laboratories, Inc. (FRX) To Discontinue NAMENDA® Tablets, Focus On Once-Daily NAMENDA XR® 2/17/2014
Sanofi (France) (SAN.PA) Suffers Another Setback, Ditches Late-Stage Bone Marrow Cancer Drug 11/19/2013
ImmunoGen, Inc. (IMGN) Discontinues Study as Lung Cancer Drug Flops; Stock Crashes -18.97%% at Market Close (November 5, 2013) 11/6/2013
Imprimis Pharmaceuticals (immy) to Shift Focus, Discontinues Impracor Phase 3 Program to Focus on Other Areas 11/6/2013
Ariad Pharmaceuticals, Inc. (ARIA) Discontinues Phase 3 Study of Cancer Drug Iclusig; Shares Decimated, Falls -40.67% at Market Close (October 18, 2013) 10/22/2013
Medivir AB (MVIRb.F), Daewoong Pharmaceutical Co., Ltd. Discontinue Hepatitis B Drug Development 9/6/2013
Medivir AB (MVIRb.F) Makes Strategic Decision to Discontinue its NS5A Inhibitor Program 8/15/2013
Albany Molecular Research, Inc. (AMRI) (AMRI): Bristol-Myers Squibb Company (BMY) Stops Development of Depression Drug 8/14/2013
Isis Pharmaceuticals, Inc. (ISIS) Ditches Rheumatoid Arthritis Drug After Phase 2 Trial Disappoints 8/6/2013
Higher Death Rates Force Celgene Corporation (CELG) to End Blood Cancer Trial 7/22/2013
Roche (RHHBY) Halts Diabetes Drug Trial in Blow to Pipeline 7/12/2013
Roche (RHHBY) Backs Out on Seaside Therapeutics Drug Trial for Fragile X. Parents Dismayed 6/11/2013
Sanofi (France) (SAN.PA) Pulls the Plug on Two Late-Stage Drugs, Plans $285 Million Charge 6/4/2013
Pfizer Inc. (PFE) Halts Study of Non-Hodgkin's Lymphoma Drug 5/29/2013
Merck & Co., Inc. (MRK) Drops Development of Parkinson's Drug 5/28/2013
Eli Lilly and Company (LLY) to Take $30 Million Charge After Cancer Drug Fails Phase 3 Trial 5/15/2013
CytRx Corporation (CYTR) Ditches Lung Cancer Drug After Phase 2 Trial Failure 5/10/2013
Bayer AG (BAY.F) Halts Study of Hemophilia Therapy BAY 86-6150 Due to Safety Concerns 5/7/2013
Celltrion, Inc. Drops Late-Stage Trial of Roche (RHHBY) Rituxan Drug Copy 4/19/2013
Liver Toxicity Brings Melanoma Study on Bristol-Myers Squibb Company (BMY)/Roche (RHHBY) Drugs to a Halt 4/4/2013
Clavis Pharma ASA Stops Elacytarabine Development on Negative Ph3 Trial in AML 4/3/2013
ZIOPHARM Oncology, Inc. (ZIOP.OB) Cancer Drug Fails in Late-Stage Trial; Shares Plunge 3/27/2013
BioLineRx Ltd. Says CLARITY Trial of BL-1020 Did Not Meet Primary Efficacy Endpoint, to Discontinue Study 3/21/2013
Pfizer Inc. (PFE) Halts Development of Hepatitis C Drug 3/19/2013
Moberg Derma Discontinues Clinical Development of Limtop 3/11/2013
AEterna Zentaris (AEZS) to Discontinue Phase 3 Trial in Multiple Myeloma With Perifosine 3/11/2013
FDA Halts Amgen (AMGN) Trial After Teen Death 3/4/2013
Amgen (AMGN), UCB, Inc. (UCBJF.PK) Halt Testing of Fracture-Healing Drug 2/13/2013
Eli Lilly and Company (LLY) to Cease Tabalumab Phase 3 RA Program 2/8/2013
Idenix Pharmaceuticals, Inc. (IDIX) Halts Development of Two Hepatitis C Treatments 2/6/2013
Vanda Pharmaceuticals, Inc. (VNDA) to Stop Developing Anti-Depressant 2/1/2013
What Merck & Co., Inc. (MRK) Told Doctors About Tredaptive Before It Stopped Selling It 1/15/2013
Merck & Co., Inc. (MRK) Pulls Tredaptive Cholesterol Pill After a Flop 1/14/2013
Tranzyme Pharma (TZYM) Stops Mid-Stage Gastric Study After Drug Fails 12/18/2012
Boehringer Ingelheim Corporation Ends Phase 2 Trial of Dabigatran in Mechanical Valve Patients 12/13/2012
Geron Corporation (GERN) Ends Brain Cancer Drug Study, Cuts 43 Jobs 12/10/2012
Bristol-Myers Squibb Company (BMY) Drops Alzheimer's Drug on Little Benefit 12/5/2012
Ranbaxy Laboratories (RANBAXY.BO) Halts Production of Generic Lipitor 12/3/2012
Merck & Co., Inc. (MRK) Shelves Development of Another Diabetes-Cholesterol Program 11/14/2012
Roche (RHHBY)'s Good Cholesterol Drug Shows Negative Side Effects 11/7/2012
Bioniche Life Sciences Inc. (BNC) Discontinues Current Phase 3 Clinical Trial With Urocidin™ 11/5/2012
Ex-Geron Corporation (GERN) CEO Launches Effort to Revive Lost Stem Cell Program 10/29/2012
Abbott Laboratories (ABT), Reata Pharmaceuticals, Inc. Kidney Disease Drug Trial Stopped 10/22/2012
Novartis AG (NVS) Stops Developing Long-Acting Version of Vanda Pharmaceuticals, Inc. (VNDA)'s Fanapt 10/12/2012
Oxford BioMedica PLC (OXB.L) Abandons Prostate Cancer Vaccine Study 10/11/2012
Anacor Pharmaceuticals, Inc. Says GlaxoSmithKline (GSK) Stops Development of Antibiotic 10/8/2012
ArQule, Inc. (ARQL), Daiichi Sankyo, Inc. (4568.t) Discontinue Lung Cancer Drug Trial 10/3/2012
Novo Nordisk A/S (NVO) Halts Development of Hemophilia Drug 10/2/2012
Vertex Pharmaceuticals (MA) (VRTX) Ends Work on One Hepatitis C Drug, Continues Another 9/26/2012
Astex Pharmaceuticals (ASTX) Ends Development of Lung Cancer Drug 9/24/2012
Targacept, Inc. (TRGT) to Cut More Jobs, Halt ADHD Drug Development After Failed Phase 2 Trial 9/18/2012
Johnson & Johnson (JNJ) Ends Trial of Skin-Disorder Drug Over Adverse Events 9/17/2012
Lundbeck Inc. (LUN.CO) Halts Sales of Leukemia Drug Over Supply Problems 9/17/2012
Geron Corporation (GERN) Ends Breast Cancer Study of Imetelstat 9/11/2012
Zalicus Inc. (ZLCS) to Halt Further Clinical Development With Synavive 9/10/2012
Palatin Technologies (PTN) Says Partner AstraZeneca PLC (AZN) to Halt Further Development of Obesity Drug 9/10/2012
Eli Lilly and Company (LLY) Ends Development of Schizophrenia Drug 8/30/2012
Bristol-Myers Squibb Company (BMY) Ends Hepatitis C Development After Patient Death; Eats a $1.8 Billion Loss 8/27/2012
Gilead Sciences, Inc. (GILD) Stops Development of PAH Drug After Missing Study Goal 8/23/2012
Pfizer Inc. (PFE), Johnson & Johnson (JNJ) Scrap Alzheimer's Drug After Phase III Study Fails 8/8/2012
Infinity Pharmaceuticals Inc. (INFI) Pulls Plug on Cancer Drug Saridegib Trials 6/19/2012
BioInvent (BOVNF), ThromboGenics NV (TBGNF) Plunges as Development of Anticoagulent is Dropped 6/5/2012
Chelsea Therapeutics, Inc. (CHTP) Halts Development of Arthritis Drug 6/1/2012
Q-Med AB Discontinues the Breast Indication for Macrolane 4/17/2012
SciClone Pharmaceuticals, Inc. (SCLN) to Discontinue Development of SCV-07 Oral Mucositis Trial 3/7/2012
Karo Bio AB Axes Clinical Dyslipidemia Program After Side Effects Surface in Animal Study 2/15/2012
Theratechnologies Inc. (TH.TO) Cuts 60% of Workforce, Refocus for 2013 12/7/2011
Sanofi (France) (SASY.PA) Discontinues Selling Authorized Generic Version of Lovenox 12/5/2011
National Institutes of Health (NIH) Discontinues Tenofovir Vaginal Gel in 'Voice' HIV Prevention Study 11/29/2011
Celgene International Sárl (CELG) Will Discontinue Phase III MAINSAIL(R) Trial in Castrate-Resistant Prostate Cancer 11/28/2011
Moberg Derma Discontinues Preclinical Development Program for A-Fizz 10/27/2011
Conatus Pharmaceuticals Inc.Terminates Phase 2 Clinical Trial of CTS-1027 10/27/2011
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Drops Europe Development of Insomnia Drug 10/10/2011
Sangamo BioSciences, Inc. (SGMO) Shares Plunge on Diabetic Neuropathy Drug Failure, to Terminate Development 10/4/2011
Astellas Pharma Inc. (YPH.BE) Halts Development of Anti-Clotting Drug 9/29/2011
FDA Issues Clinical Hold on Cancer Drug by Immunomedics, Inc. (IMMU) 9/26/2011
Eisai Inc. (ESALF.PK) Discontinues Global Development of Rabeprazole Sodium Extended-Release Capsules, 50 mg 9/6/2011
Shire plc Falls After Scrapping Dermagraft as Leg Ulcer Therapy 8/25/2011
Endo Pharmaceuticals (ENDP) Terminates Pain Program After Failed Trial; Ends Pact With Grunenthal GmbH 8/19/2011
Amylin Pharmaceuticals, Inc. (AMLN), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Halt Obesity Drug Development Following Commercial Reassessment of the Program 8/8/2011
Merck & Co., Inc. (MRK) to Cut Up to 13,000 Jobs, Q2 Profit Rises; Discontinues Ph3 Migraine Program 8/4/2011
BeiLu Pharma Gives Up on Melatonin-based Depression Drug 7/19/2011
Lack of Partner Prompts Genmab A/S (GEN.CO) to Drop Zalutumumab 6/28/2011
Diamyd Medical AB Discontinues US Phase III Trial with Type I Diabetes Product 6/24/2011
Enzon Pharmaceuticals, Inc. (ENZN) Ditches PEG-SN38 for mCRC but Continues Development in Other Cancers 5/19/2011
Drugmakers Including Johnson & Johnson (JNJ) and Procter & Gamble (PG) Eliminate Infant Drops of Key Medicine 5/5/2011
Pfizer Inc. (PFE) Stops Making Canine Tick Med Over Side Effects 4/25/2011
Galapagos NV (GLPG.BR) Discontinues Phase II Trial for GLPG0259, Focuses Resources on Other Rheumatoid Arthritis Programs 4/15/2011
StemCells Inc. (STEM) Discontinues Batten Disease Program 4/8/2011
AstraZeneca PLC (AZN) Pulls Bloodthinner In France 3/24/2011
AstraZeneca PLC (AZN) Pulls Asthma Product, Hitting SkyePharma Inc. (SKYE) 3/7/2011
Innate Pharma Drops IPH 1101 Development 3/4/2011
Pfizer Inc. (PFE) Drops 15 Pipeline Projects 3/1/2011
Sanofi-Aventis (France) (SASY.PA) to Withdraw Anzemet From Five Countries 2/15/2011
Idenix Pharmaceuticals, Inc. (IDIX) Cancels Hepatitis C Drug On Toxicity Worries; Shares Fall 2/10/2011
Hospira, Inc. (HSP) to Stop Making Drug Used in Executions 1/24/2011
Genentech (RHHBY) Informs Customers of Important Information About Triad Group's Alcohol Prep Pads 1/14/2011
More Evidence Links Roche (RHHBY)'s Avastin to Heart Failure in Breast Cancer Patients 1/6/2011
Ipsen Closes BIM 23A760 Phase II Trials For Acromegaly; Compound Does Not Meet Expectations 12/15/2010
Servier's Diabetes Drug, Mediator May Be Linked to 500 Deaths 11/16/2010
Transition Therapeutics Inc. (TTH.TO) and Eli Lilly and Company (LLY) Stops Diabetes Drug Development 9/17/2010
Basilea Pharmaceutica (BSLN.SW) Announces Discontinuation of Sale of Ceftobiprole by Janssen-Cilag AG, a Johnson & Johnson (JNJ) Company, In Switzerland 9/9/2010
Karo Bio AB Announces That Merck & Co., Inc. (MRK) Discontinues Development of Mk-6913 for Hot Flashes 9/8/2010
Shire Pharmaceuticals (SHPGY) to Pull Low Blood Pressure Drug from Market 8/18/2010
Teva Pharmaceutical Industries Limited (TEVA) Lays Off 70 as Propofol is Abandoned 8/16/2010
Pfizer Inc. (PFE) Pulls Leukemia Drug Mylotarg From U.S. Market After Deaths, No Proven Benefit 6/22/2010
Trubion Pharmaceuticals Inc. (TRBN) Says Pfizer Inc. (PFE) to Stop Development of Arthritis Drug, TRU-015 6/15/2010
Teva Pharmaceutical Industries Limited (TEVA) To Stop Manufacturing Propofol Sedative 5/28/2010
FDA Says Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available 4/14/2010
GenVec Inc. (GNVC) Says Cancer Drug Not Effective, Ends Trial 3/30/2010
Novelos Therapeutics, Inc. (NVLT) Discontinues Current Development Program for NOV-002 in NSCLC; Primary and Secondary Endpoints Not Met in Phase 3 Trial 3/18/2010
Pfizer Inc. (PFE) (JOBS) Drops 100 Drugs from Pipeline 1/29/2010
Pfizer Inc. (PFE) (JOBS) Ends Late-stage Lung-Cancer Study; Analysis Showed it Would Miss Main Goal 12/30/2009
Arena Pharmaceuticals, Inc. (ARNA) Announces Merck KGaA (MKGAF.PK) Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis 12/28/2009
Sanofi-Aventis (France) (SASY.PA) Stops Development of Two Drugs: Eplivanserin in Insomnia and Thrombosis Drug Idrabiotaparinux 12/21/2009
BioMS Medical (MS.TO) Provides Corporate Update; Company will Not Pursue Further Late Stage Clinical Trials with Dirucotide in MS 12/18/2009
Thallion Pharmaceuticals Inc. Discontinues Phase II Glioblastoma Multiforme Trial After Review of Interim Data 12/18/2009
Seattle Genetics, Inc. (SGEN) (JOBS) Stops Mid-Stage Cancer Trial 10/6/2009
SciClone Pharmaceuticals, Inc. (SCLN) (JOBS) Drops Cancer Drug Development 10/5/2009
ZymoGenetics, Inc. (ZGEN) (JOBS) Says Merck Serono Discontinues MS Trials 9/29/2009
Merck & Co., Inc. (MRK) (JOBS) Abandons One Migraine Drug MK-3207, Pursues Another 9/11/2009
Antisoma PLC (ASM.L) Announces Discontinuation of Development of AS1402 8/10/2009
Insmed Incorporated (INSM) Stops Supplying Iplex To New Patients 7/27/2009
Repros Therapeutics Inc. (RPRX) to Stop Using 50 mg Dose in Fibroids Study 7/1/2009
UCB Group (UCBJF.PK) and Biogen Idec, Inc. (Massachusetts) (BIIB) Discontinue Phase II Clinical Trial of CDP323 7/1/2009
Roche Holding AG (RHHBF.PK) Stops Selling Acne Drug Accutane 6/30/2009
ImmunoGen, Inc. (IMGN) to End Stomach-Cancer Drug Development 6/15/2009
Halozyme Therapeutics, Inc. (HALO) Not to Develop Osteoporosis Study Further 6/5/2009
Pfizer Inc. (PFE) (JOBS) Discontinues Late-stage Trial of Sunitinib in Advanced Breast Cancer 6/3/2009
Sanofi-Aventis (France) (SASY.PA) Stops 14 Candidate Drugs, Profit Up 15% 4/29/2009
Targacept, Inc. (TRGT) Provides Update on TC-6499 and Pain Program in GlaxoSmithKline (GSK) Alliance - Data Does Not Support Further Development 3/11/2009
Pfizer Inc. (PFE) Drops Development of 2 Late-Stage Drugs 2/24/2009
Enzon Pharmaceuticals, Inc. (ENZN) Discontinues Further Development of rhMBL 2/10/2009
Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update 1/29/2009
Akesis Pharmaceuticals Discontinues Sole Clinical Development Program and Announces Intent to File for Chapter 7 Bankruptcy 1/22/2009
Nile Therapeutics, Inc. Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 1/20/2009
Neurobiological Technologies, Inc. (NTII) Ends Stroke Drug Development; Cuts Jobs 1/13/2009
EpiCept Corporation (EPCT) Discontinues Drug Discovery Operations and Reduces Workforce 1/12/2009
Avigen, Inc. (AVGN) Stops Development of Lead Drug; Reduces Headcount by 70% 12/22/2008
SkyePharma Inc. (SKYE) Ceases Commercialization of formoterol Certihaler(R) in the United States 12/19/2008
Adolor Corporation (ADLR) to Stop Development of Bowel Dysfunction Drug 12/18/2008
Solvay Pharmaceuticals, Inc. Ends Research on Cbesity Treatment Compound 11/17/2008
Pfizer Inc. (PFE) (JOBS) Ends Development of Obesity Drug 11/6/2008
Sanofi-Aventis (France) (SASY.PA) Ends Research on Troubled Diet Drug, Accomplia 11/6/2008
Mayo Clinic Cuts Clinical Trial Services Business; Jobs Affected 11/6/2008
ZymoGenetics, Inc. (ZGEN) Kidney Disease Drug Study Stopped 10/28/2008
Biogen Idec, Inc. (Massachusetts) (BIIB) (JOBS) To Discontinue Rheumatoid Arthritis Drug As Drug Fails To Meet Primary, Secondary Endpoints 10/10/2008
Genmab A/S (GNMSF.PK) Announces Discontinuation of Zanolimumab Program and Job Cuts 10/8/2008
Life Science Weekly inSite (Sep. 29 - Oct. 3) 10/6/2008
Merck & Co., Inc. (MRK) (JOBS) Discontinues Development of Investigational Medicine Taranabant for Obesity 10/2/2008
Most Failed Clinical Trials Are Never Published 9/23/2008
Valens Pharma Ltd. Announces Next Steps; Company Has Suspended Work on its DCA i.v Program 8/6/2008
EMD Serono, Inc. to Discontinue Geref Diagnostic 8/5/2008
Ambrilia Biopharma Inc. Provides Update on PPL-100; Merck & Co., Inc. (MRK) (JOBS) Places Development Hold on Drug 7/28/2008
Progen Pharmaceuticals Limited (PGLA) Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 7/24/2008
MethylGene and Celgene (CELG) Announce Precautionary Suspension of New Enrollments Into MGCD0103 Clinical Trials 7/23/2008
National Institute of Allergy And Infectious Diseases (NIAID) Will Not Move Forward with the PAVE 100 HIV Vaccine Trial 7/18/2008
Jury Finds Johnson & Johnson (JNJ) (JOBS) Not Liable in Motrin Lawsuit 7/18/2008
DUSA Pharmaceuticals (DUSA) Announces Update on Nicomide(R); Company Places Voluntary Hold on Existing Inventory 7/18/2008
Infinity Pharmaceuticals, Inc. Discontinues Phase 2 Signal-Finding Clinical Study of IPI-504 in Advanced Prostate Cancer 7/16/2008
BioAlliance Pharma Suspends Phase II/III Trial of Doxorubicin Transdrug(R) in Primary Liver Cancer 7/16/2008
ADVENTRX Pharmaceuticals Inc. (ANX) Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R) 7/1/2008
Novexel Discontinues Development of NXL 101 6/30/2008
Gene-testing Firms Under Fire 6/16/2008
Novo Nordisk A/S (NVO) Discontinues Phase 3 Clinical Trial with NovoSeven(R) in Trauma 6/11/2008
AVI BioPharma, Inc. (AVII) Provides Update on New Business Plan: Discontinues Drug Program, Cuts Jobs 6/10/2008
EXACT Sciences Corporation (EXAS) Reports on Laboratory Corporation of America Holdings (LH)'s Plans to Launch a New Laboratory-developed Stool-based DNA Screening Test for Colorectal Cancer in 2008; LabCorp Stopped Offering PreGen-Plus 6/5/2008
Merck & Co., Inc. (MRK) Ends Study of Cholesterol Drug 5/21/2008
Dynavax Technologies Corporation (DVAX) Ends Development Of Allergy Drug Tolamba After Trial Failure 5/16/2008
Pharmexa A/S (PHARMX.CO) Stops One of Two Phase III Trials 5/13/2008
SGX Pharmaceuticals, Inc. (SGXP) Discontinued Development of SGX523; Announces First Quarter Financial Results 5/13/2008
King Pharmaceuticals®, Inc. Announces Tilade Inhaler to be Discontinued 5/2/2008
NUCRYST Pharmaceuticals Corp. (WEDX) Announces Management Realignment and R&D Portfolio Change; Discontinued Development of NPI 32101 for Inflammatory Bowel Disease (IBD) 5/1/2008
Replidyne, Inc. (RDYN) Discontinues Phase III Trial to Conserve Cash 4/23/2008
Inspire Pharmaceuticals, Inc. (ISPH) to Discontinue Development of Epinastine Nasal Spray 4/23/2008
Synexus' AstraZeneca PLC (AZN)'s Crestor Jupiter Study Stopped Early 4/18/2008
Elan Corporation PLC (ELN), Wyeth (WYE) Suspend Alzheimer's Vaccine Study 4/18/2008
ViroPharma Incorporated (VPHM) and Wyeth Pharmaceuticals End Development of Hepatitis C Drug 4/17/2008
Eisai Company, Ltd. (ESALY.PK) to Drop E2007 Development for Parkinson's Disease 4/11/2008
ArQule, Inc. (ARQL) Provides Clinical Update on E2F-1 Program; Company Plans to Stop Further Clinical Testing 4/10/2008
Pfizer Inc. (PFE) Announces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma 4/2/2008
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Says to Drop Development of Cholesterol Drug 3/28/2008
Keryx Biopharmaceuticals (KERX) Announces Termination of SUN-MACRO Phase 4 Trial 3/28/2008
Sonus Pharmaceuticals, Inc. (SNUS) Ends Discovery Efforts of Two Programs and Reduces its Headcount 3/25/2008
EPIX Pharmaceuticals, Inc. (EPIX) to Stop Clinical Development of Depression Drug 3/20/2008
Nuvelo, Inc. (NUVO) Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 3/18/2008
Genitope Corporation (GTOP) Stops Cancer Vaccine Program, Looking at Finances 3/11/2008
Alkermes (ALKS) Receives Notice from Eli Lilly and Company (LLY) Terminating Inhaled Insulin Program 3/7/2008
Alkermes (ALKS) Provides Update on Inhaled Insulin Program; Eli Lilly and Company (LLY) Expected to Discontinue the Program 3/7/2008
Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Inc., Announces the Discontinuation of the Development Program for Pafuramidine 2/25/2008
Baxter International, Inc. (BAX) Halts Heparin Production Amid Reactions 2/12/2008
Eli Lilly and Company (LLY) Announces Discontinuation of Humatin (Paromomycin Sulfate Capsules, USP) 2/8/2008
Neose Technologies, Inc. (NTEC) Announces Discontinuation of NE-180 Program; Job Cuts 1/30/2008
NMT Medical, Inc (NMTI) Terminates Further Enrollment in MIST II 1/23/2008
Bayer HealthCare Pharmaceuticals (BAY) Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 1/23/2008